Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: Under the threat of N. meningitidis serogroup W135

Tropical Medicine and International Health

Volumn 10, Issue 5, 2005, Pages 435-443

  Boisier, Pascal ^a   Djibo, Saacou ^a   Sidikou, Fati ^a   Mindadou, Habsatou ^a   Kairo, Kiari Kaka ^b   Djibo, Ali ^c   Goumbi, Kadade ^b   Chanteau, Suzanne ^a  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b Ministere de la Sante   (Niger)

^c Direction Générale de la Santé Publique DGSP Ministère de la Santé   (Niger)

Author keywords

Burkina Faso; Epidemic; Meningitis; Neisseria meningitidis W135; Niger

Indexed keywords

EPIDEMIOLOGY; MENINGITIS;

ARTICLE; BACTERIUM IDENTIFICATION; CEREBROSPINAL FLUID ANALYSIS; EPIDEMIC; EPIDEMIC MENINGITIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; NIGER; SCHOOL CHILD;

ANTI-INFECTIVE AGENTS; CHILD; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP W-135; NIGER; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; SEASONS;

AFRICA; EASTERN HEMISPHERE; NIGER [WEST AFRICA]; SUB-SAHARAN AFRICA; WEST AFRICA; WORLD;

NEISSERIA MENINGITIDIS;

EID: 19044399844     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01394.x     Document Type: Article

References (23)

1. Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L & Chippaux J-P (1999) Epidemiology of bacterial meningitis in Niamey, Niger 1981-96. Bulletin of the World Health Organization 77, 499-508.
2. Denis F, Rey J-L, Amadou A et al. (1982) Emergence of meningococcal meningitis caused by W 135 subgroup in Africa. Lancet 2, 1335-1336.
3. Djibo S, Nicolas P, Alonso J-M et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Tropical Medicine and International Health 8, 1118-1123.
4. Etienne J, Sperber G, Adamou A & Picq JJ (1990) Notes épidémiologiques: les méningites à méningocoques de sérogroupe X à Niamey (Niger). Médecine Tropicale 50, 227-229.
5. Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS & Moxon ER (1994) PCR for capsular typing of Haemophilus influenzae. Journal of Clinical Microbiology 32, 2382-2386.
6. Gagneux S, Wirth T, Hodgson A et al. (2002a) Clonal groupings in serogroup X Neisseria meningitidis. Emerging Infectious Diseases 8, 462-466.
7. Gagneux SP, Hodgson A, Smith TA et al. (2002b) Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. Journal of Infectious Diseases 185, 618-626.
8. Garcia P, Garcia JL, Garcia E & Lopez R (1986) Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli. Gene 43, 265-272.
9. Greenwood B (1999) Manson Lecture. Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341-353.
10. Guiver M, Borrow R, Marsh J et al. (2000) Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunology and Medical Microbiology 28, 173-179.
11. Jodar L, LaForce FM, Ceccarini C, Aguado T & Granoff DM (2003) Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet 361, 1902-1904.
12. Kwara A, Adegbola RA, Corrah PT et al. (1998) Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Tropical Medicine and International Health 3, 742-746.
13. Lapeyssonnie L (1963) La méningite cérébro-spinale en Afrique. Bulletin of the World Health Organization 28 (Suppl.), 3-114.
14. MacLennan JM, Urwin R, Obaro S, Griffiths D, Greenwood B & Maiden MC (2000) Carriage of serogroup W-135, ET-37 meningococci in the Gambia: implications for immunisation policy? Lancet 356, 1078.
15. Nicolas P, Décousset L, Riglet V, Castelli P, Stor R & Blanchet G (2001) Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infectious Diseases 7, 849-854.
16. Nicolas P, Djibo S, Moussa A, Tenebray B, Boisier P & Chanteau S (2005) Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A Sequence Type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains. Journal of Clinical Microbiology 43, 1437-1438.
17. Ouedraogo-Traore R, Hoiby EA, Sanou I et al. (2002) Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001. Scandinavian Journal of Infectious Diseases 34, 804-807.
18. Sidikou F, Djibo S, Taha MK et al. (2003) Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger. Emerging Infectious Diseases 9, 1486-1488.
19. Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 38, 855-857.
20. Taha MK, Parent Du Chatelet I, Schlumberger M et al. (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. Journal of Clinical Microbiology 40, 1083-1084.
21. World Health Organization (1998) Control of Epidemic Meningococcal Disease. WHO Practical Guidelines, 2nd edn. Document WHO/EMC/BAC/98.3. WHO, Geneva.
22. World Health Organization (2002) Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report 2002. Weekly Epidemiological Record 77, 152-155.
23. World Health Organization (2003) Outbreak news. Meningococcal disease, Burkina Faso. Weekly Epidemiological Record 78, 33.